anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Problem Agitate Solution

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 26,550
Current window 21,631-21,660
Pages 885
Rows per page 30
Arc: Problem Agitate Solutionclear collectionreset all
18 30 60

Arc

21,631-21,660 of 26,550

filter-aware
12
The slide uses a biological process diagram to illustrate how PrimeC modulates microRNA regulation, TDP-43 aggregation, and cellular recycling.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
23
NeuroSense Therapeutics | Investor Presentation Deck | 34 slidesNeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
24
NeuroSense Therapeutics | Investor Presentation Deck | 34 slidesNeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
25
The slide includes a progress bar at the bottom indicating the current section is 'Summary'.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
26
The slide serves as a media/press coverage page, likely for an appendix.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
27
Includes stock price, market cap, cash position, and analyst coverage.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
28
Includes a team photo and a progress bar at the bottom indicating the current slide is the 'Summary' section.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
29
NeuroSense Therapeutics | Investor Presentation Deck | 34 slidesNeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
30
This is a highly emotional, narrative-driven slide used to ground the company's mission in a personal story.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
31
The chart shows a negative correlation trend line between TDP-43 change and ALSFRS-R slope.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
32
NeuroSense Therapeutics | Investor Presentation Deck | 34 slidesNeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
33
The slide serves as a press clipping or media coverage appendix.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
34
Includes a navigation bar at the bottom indicating the current section is 'Phase 2b'.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
06
OKYO Pharma | Results Presentation Deck | 25 slidesOKYO Pharma | Results Presentation Deck | 25 slides · OKYO Pharma
Conference presentation Investor relations Beat · Problem1 hit
07
The slide uses a table to frame the problem by contrasting existing market solutions with their clinical and commercial shortcomings.OKYO Pharma | Results Presentation Deck | 25 slides · OKYO Pharma
Conference presentation Investor relations Beat · Problem1 hit
15
OKYO Pharma | Results Presentation Deck | 25 slidesOKYO Pharma | Results Presentation Deck | 25 slides · OKYO Pharma
Conference presentation Investor relations Beat · Agitate1 hit
16
The slide uses a diagram to explain the surgical model and a bar chart to show the comparative efficacy results over 14 days.OKYO Pharma | Results Presentation Deck | 25 slides · OKYO Pharma
Conference presentation Investor relations Beat · Agitate1 hit
17
The slide uses a circular diagram to represent the 'Dry Eye Cycle' and overlays the drug's mechanism of action as an intervention.OKYO Pharma | Results Presentation Deck | 25 slides · OKYO Pharma
Conference presentation Investor relations Beat · Solution1 hit
03
The slide uses a 2x2 grid layout to illustrate the lack of focus or scale in the company's business units.Sarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Problem Statement1 hit
04
The slide uses a waterfall-style bridge to visualize the components of value (Net Cash, Commercial Franchise, Royalties, Manufacturing, Prudent R&D Spend) that contribute to the 'optimal' valuation.Sarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Logic Chain1 hit
05
Sarissa Capital | Activist Presentation Deck | 95 slidesSarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Logic Chain1 hit
06
The slide uses a series of company logos and acquisition metrics to establish credibility.Sarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Logic Chain1 hit
07
Sarissa Capital | Activist Presentation Deck | 95 slidesSarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Logic Chain1 hit
08
Uses a visual metaphor of a gap/chasm between the two parties.Sarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Logic Chain1 hit
09
Includes branding elements (Sarissa Capital logo and Spartan icon).Sarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Logic Chain1 hit
10
Sarissa Capital | Activist Presentation Deck | 95 slidesSarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Logic Chain1 hit
11
The slide uses a visual bridge to emphasize the delta between the two indices.Sarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Logic Chain1 hit
12
The slide uses a visual gap analysis to emphasize the underperformance of ALKS relative to its peers.Sarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Logic Chain1 hit
13
The chart uses a visual bridge to emphasize the performance delta between the indices and ALKS.Sarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Logic Chain1 hit
14
Uses a visual metaphor (roller coaster) to imply volatility and cyclical failure.Sarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Logic Chain1 hit